DACS
NBP

Dymon Asia Capital (Singapore)’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-80,400
Closed -$198K – 280
2026
Q1 		$198K Hold
80,400
– – 0.02% 228
2025
Q4 		$320K Buy
+80,400
New +$356K 0.03% 210

Other funds holding NBP

AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM

Dymon Asia Capital (Singapore)'s NBP Position: Q2 2026 in Review

Dymon Asia Capital (Singapore) sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2026, closing a stake of 80,400 shares — an estimated $198K sold.

Dymon Asia Capital (Singapore) first reported a position in NBP in Q4 2025 and held it in 2 quarters. The position peaked at $320K in Q4 2025. 6 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • Dymon Asia Capital (Singapore) reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2026 after selling out during the quarter.
  • Dymon Asia Capital (Singapore) sold 80,400 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $198K.
  • Dymon Asia Capital (Singapore) first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2025 and held it in 2 quarters.
  • Dymon Asia Capital (Singapore)'s NovaBridge Biosciences American Depositary Shares position peaked at $320K in Q4 2025.
  • 6 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q2 2026, filed 23 Jul 2026.